832-497-2220 info@mybiogate.com

Ambrx partners with BeiGene to Develop Next-Generation Biologics

March, 2019, Ambrx, Inc. and BeiGene, Ltd announced a global research and development collaboration.  BeiGene is a global, commercial-stage, research-based biotechnology company focused on immuno-oncology cancer therapeutics. With a team of over 2,200 employees in...